Neither BPC-157 nor TB-500 has received FDA approval for human use, placing them in the category of research compounds without official safety data in humans
It focuses, as youd expect, on obesity-related weight loss and type 2 diabetes although other metabolic conditions get a look-in, too
Step 3: FDA Review Period (6 to 10 Months) Once the FDA accepts the NDA for review, it has 10 months for a Standard Review or 6 months for a Priority Review
Parent and teacher interviews Parents and teachers provide insights into behaviour patterns and developmental history
The peptide is often used in skin rejuvenation therapy reducing fine lines, smooth rough skin, and improving tissue renewal
Additionally, the medication should be used with a reduced-calorie diet and increased physical activity